Boehringer Ingelheim Int. GmbH
- A10 - Antidiabéticos
- GLYXAMBI film-coated tablet 10 mg+5 mg
- GLYXAMBI film-coated tablet 25 mg+5 mg
- JARDIANCE film-coated tablet 10 mg
- JARDIANCE film-coated tablet 25 mg
- JENTADUETO film-coated tablet 1 000 mg+2.5 mg
- JENTADUETO film-coated tablet 850 mg+2.5 mg
- SYNJARDY film-coated tablet 12.5 mg+1 000 mg
- SYNJARDY film-coated tablet 12.5 mg+850 mg
- SYNJARDY film-coated tablet 5 mg+1 000 mg
- SYNJARDY film-coated tablet 5 mg+850 mg
- TRAJENTA film-coated tablet 5 mg
- B01 - Agentes antitrombóticos
- ACTILYSE CATHFLO powder and solvent for solution for injection 2 mg
- ACTILYSE powder and solvent for solution for injection 10 mg+10 ml
- ACTILYSE powder and solvent for solution for injection 20 mg+20 ml
- ACTILYSE powder and solvent for solution for injection 50 mg+50 ml
- METALYSE powder and solvent for solution for injection 10 000 IU(50 mg)+10 ml
- METALYSE powder and solvent for solution for injection 6 000 IU(30 mg)+6 ml
- METALYSE powder and solvent for solution for injection 8 000 IU(40 mg)+8 ml
- PRADAXA capsule, hard 110 mg
- PRADAXA capsule, hard 150 mg
- PRADAXA capsule, hard 75 mg
- PRADAXA granules 110 mg
- PRADAXA granules 150 mg
- PRADAXA granules 20 mg
- PRADAXA granules 30 mg
- PRADAXA granules 40 mg
- PRADAXA granules 50 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- MICARDIS tablet 20 mg
- MICARDIS tablet 40 mg
- MICARDIS tablet 80 mg
- MICARDISPLUS tablet 40 mg+12.5 mg
- MICARDISPLUS tablet 80 mg+12.5 mg
- MICARDISPLUS tablet 80 mg+25 mg
- TWYNSTA tablet 40 mg+10 mg
- TWYNSTA tablet 40 mg+5 mg
- TWYNSTA tablet 80 mg+10 mg
- TWYNSTA tablet 80 mg+5 mg
- J05 - Antivirales de uso sistémico
- APTIVUS capsule, soft 250 mg
- APTIVUS oral solution 100 mg/ml
- VIRAMUNE oral suspension 50 mg/5 ml
- VIRAMUNE prolonged-release tablet 100 mg
- VIRAMUNE prolonged-release tablet 400 mg
- VIRAMUNE tablet 200 mg
- L01 - Antineoplásicos
- GIOTRIF film-coated tablet 20 mg
- GIOTRIF film-coated tablet 30 mg
- GIOTRIF film-coated tablet 40 mg
- GIOTRIF film-coated tablet 50 mg
- OFEV capsule, soft 100 mg
- OFEV capsule, soft 150 mg
- VARGATEF capsule, soft 100 mg
- VARGATEF capsule, soft 150 mg
- N04 - Antiparkinsonianos
- MIRAPEXIN prolonged-release tablet 0.26 mg
- MIRAPEXIN prolonged-release tablet 0.52 mg
- MIRAPEXIN prolonged-release tablet 1.05 mg
- MIRAPEXIN prolonged-release tablet 1.57 mg
- MIRAPEXIN prolonged-release tablet 2.1 mg
- MIRAPEXIN prolonged-release tablet 2.62 mg
- MIRAPEXIN prolonged-release tablet 3.15 mg
- MIRAPEXIN tablet 0.088 mg
- MIRAPEXIN tablet 0.18 mg
- MIRAPEXIN tablet 0.35 mg
- MIRAPEXIN tablet 0.7 mg
- MIRAPEXIN tablet 0.88 mg
- MIRAPEXIN tablet 1.1 mg
- SIFROL prolonged-release tablet 0.26 mg
- SIFROL prolonged-release tablet 0.52 mg
- SIFROL prolonged-release tablet 1.05 mg
- SIFROL prolonged-release tablet 1.57 mg
- SIFROL prolonged-release tablet 2.1 mg
- SIFROL prolonged-release tablet 2.62 mg
- SIFROL prolonged-release tablet 3.15 mg
- SIFROL tablet 0.088 mg
- SIFROL tablet 0.18 mg
- SIFROL tablet 0.35 mg
- SIFROL tablet 0.7 mg
- SIFROL tablet 1.1 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- SPIOLTO RESPIMAT pressurised inhalation, solution 2.5 µg/dose+2.5 µg/dose
- SPIRIVA inhalation powder, hard capsule 18 µg
- SPIRIVA RESPIMAT pressurised inhalation, solution 2.5 µg/dose
- STRIVERDI RESPIMAT pressurised inhalation, solution 2.5 µg/dose
- V03 - Todos los demás preparados terapéuticos
- PRAXBIND solution for injection 2.5 g/50 ml